Conference Presentation: Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial

In this post hoc Bayesian analysis of the EOLIA trial comparing the effects on mortality of venovenous extracorporeal membrane oxygenation (ECMO) vs conventional mechanical ventilation for management of severe acute respiratory distress syndrome (ARDS), the posterior probability of mortality benefit (relative risk <1) ranged between 88% and 99% given a range of prior assumptions reflecting varying degrees of skepticism and enthusiasm regarding previous evidence for the benefit of ECMO. Ewan C. Goligher, MD, PhD, of the University of Toronto in Canada presents findings from the analysis at the European Society of Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.